Patient Leaflet Updated 27-Jul-2022 | Glenmark Pharmaceuticals Europe Ltd
Desloratadine Glenmark 5 mg Tablets
Desloratadine 5 mg tablets
1. What Desloratadine 5 mg Tablets are and what they are used for
2. What you need to know before you take Desloratadine 5 mg Tablets
3. How to take Desloratadine 5 mg Tablets
4. Possible side effects
5. How to store Desloratadine 5 mg Tablets
6. Contents of the pack and other information
Desloratadine 5 mg Tablets contain desloratadine which is an antihistamine.
Desloratadine 5 mg Tablets is an antiallergy medicine that does not make you drowsy. It helps control your allergic reaction and its symptoms.
Desloratadine relieves symptoms associated with allergic rhinitis (inflammation of the nasal passages caused by an allergy, hay fever or allergy to dust mites) in adults and adolescents 12 years of age and older. These symptoms include sneezing, runny or itchy nose, itchy palate, and itchy, red or watery eyes.
Desloratadine is also used to relieve symptoms of urticaria (a skin condition caused by an allergy). These symptoms include itching and hives.
Relief of these symptoms lasts a full day and helps you to resume your normal daily activities and sleep.
Talk to your doctor, pharmacist or nurse before taking Desloratadine:
Do not give this medicine to children less than 12 years of age.
There are no known interactions of desloratadine with other medicines.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Desloratadine Glenmark may be taken with or without a meal.
Use caution when taking Desloratadine Glenmark with alcohol.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor, or pharmacist for advice before taking this medicine.
Taking Desloratadine is not recommended if you are pregnant or nursing a baby.
Fertility
There is no data available on male/female fertility.
At the recommended dose, this medicine is not expected to affect your ability to drive or use machines. Although most people do not experience drowsiness, it is recommended not to engage in activities requiring mental alertness, such as driving a car or operating machinery until you have established your own response to the medicinal product.
If you have been told by your doctor that you have an intolerance to some sugars, talk to your doctor before taking this medicinal product.
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
The recommended dose is one tablet once a day, with water with or without food.
This medicine is for oral use.
Swallow the tablet whole.
Regarding the duration of treatment, your doctor will determine the type of allergic rhinitis you are suffering from and will decide for how long you should take Desloratadine Glenmark. If your allergic rhinitis is intermittent (presence of symptoms for less than 4 days per week or for less than 4 weeks), your doctor will recommend you a treatment schedule that will depend on the evaluation of the history of your disease.
If your allergic rhinitis is persistent (presence of symptoms for 4 days or more per week and for more than 4 weeks), your doctor may recommend you a longer term treatment.
For urticaria, the duration of treatment may be variable from patient to patient and therefore you should follow the instructions of your doctor.
Take Desloratadine only as it is prescribed for you. No serious problems are expected with accidental overdose. However, if you take more desloratadine than you were told to, tell your doctor, pharmacist or nurse immediately.
If you forget to take your dose on time, take it as soon as possible, then go back to your regular dosing schedule. Do not take a double dose to make up for a forgotten dose.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
During the marketing of Desloratadine 5 mg Tablets, cases of severe allergic reactions (difficulty in breathing, wheezing, itching, hives and swelling of the face, tongue or throat) have been reported very rarely. If you notice any of these serious side effects, stop taking the medicine and seek urgent medical advice straight away.
In clinical studies in adults, side effects were about the same as with a dummy tablet. However, fatigue, dry mouth and headache were reported more often than with a dummy tablet. In adolescents, headache was the most commonly reported side effect.
In clinical studies with Desloratadine 5 mg Tablets, the following side effects were reported as:
Common: the following may affect up to 1 in 10 people
Adults
During the marketing of Desloratadine 5 mg Tablets, the following side effects were reported as:
Very rare: the following may affect up to 1 in 10,000 people
Not known: frequency cannot be estimated from the available data
Children
Not known: frequency cannot be estimated from the available data
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via Yellow Card Scheme (Website: www.mhra.gov.uk/yellowcard). By reporting side effects you can help provide more information on the safety of this medicine.
Keep out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The expiry date refers to the last day of that month.
This medicine does not require any special storage conditions.
Do not use this medicine if you notice any changes in the appearance of the tablets.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.
Desloratadine tablets are off-white to light-pink, circular, biconvex tablets with ‘L5’ engraved on one side and plain on the other side.
The tablets are available in blister packs containing 7, 10, 14, 15, 20, 28, 30, 50 or 100 tablets. Not all pack sizes may be marketed.
This leaflet was last revised in 07/2022.
Building 2, Croxley Park, Watford, WD18 8YA
+44 (0)1923 251137
www.glenmarkpharma.com
+44 (0)1923 202 950
0800 458 0383
+44 (0)1923 202 950
